Journal of travel medicine
-
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective.
Given China’s relatively weak innovative and regulatory capacity compared with developed countries, China’s progress on COVID-19 vaccines is especially impressive. We summarize three key lessons from China’s experience with COVID-19 vaccine R&D: (i) set strategic vaccine R&D goals and achieve broad consensus; (ii) strengthen coordination across government agencies and (iii) adopt the state-driven collaborative model.
-
We posit from our ecological analysis of COVID-19 trends that the focus on returning international emigrants helped the Indian State of Kerala to successfully mitigate transmission from emigrants. However, the state’s failure to prevent SARS-COV-2 seeding by returning domestic migrants from other states of India led to extensive community transmission.
-
Although tick-borne pathogens have been reported as an important cause of imported fever, the incidence of Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis (HGA), in travellers is unknown. ⋯ Diagnosis of HGA and empirical treatment with doxycycline should be considered in travellers with fever.